BENJAMIN RODIMEL: Open Payments
NPI 1104568963 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $60 |
| Novo Nordisk Inc | 3 | $55 |
| ABBVIE INC. | 2 | $38 |
| Insulet Corporation | 1 | $30 |
| Astellas Pharma US Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, NURTEC ODT, Omnipod, ELIQUIS, Veozah, TRINTELLIX, JARDIANCE, GEMTESA.
Industry payments across IN — which companies pay providers there.
